(Q45772798)

15 December 2017

title

Mother-to-child transmission of human T-lymphotropic virus type II. (English)

1 reference

15 December 2017

author name string

Van Dyke RB

1 reference

15 December 2017

Heneine W

1 reference

15 December 2017

Perrin ME

1 reference

15 December 2017

Rudolph D

1 reference

15 December 2017

Starszak E

1 reference

15 December 2017

Woods T

1 reference

15 December 2017

Switzer WM

1 reference

15 December 2017

Kaplan JE

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 December 1995

1 reference

15 December 2017

The Journal of Pediatrics

published in

1 reference

15 December 2017

volume

127

1 reference

15 December 2017

issue

1 reference

15 December 2017

page(s)

924-928

1 reference

15 December 2017

Segregation of human T cell lymphotropic virus type I and II infections by antibody reactivity to unique viral epitopes

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970029-3

Seminars in medicine of the Beth Israel Hospital, Boston. Pathogenesis of diseases induced by human lymphotropic virus type I infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970029-3

Chronic neurodegenerative disease associated with HTLV-II infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970029-3

Association of '(tropical) ataxic neuropathy' with HTLV-II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970029-3

Low risk of mother-to-child transmission of human T lymphotropic virus type II in non-breast-fed infants. The NYC Perinatal HIV Transmission Collaborative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970029-3

Evidence for sexual and mother-to-child transmission of human T lymphotropic virus type II among Guaymi Indians, Panama

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970029-3

Guidelines for counseling persons infected with human T-lymphotropic virus type I (HTLV-I) and type II (HTLV-II). Centers for Disease Control and Prevention and the U.S.P.H.S. Working Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970029-3

Sensitive and specific polymerase chain reaction assays for diagnosis of human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infections in HTLV-I/II-seropositive individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970029-3

Evidence for mother-to-child transmission of human T lymphotropic virus type II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970029-3

Detection of HTLV-II in breastmilk of HTLV-II infected mothers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970029-3

Characterization of antibody reactivity to human T-cell lymphotropic virus types I and II using immunoblot and radioimmunoprecipitation assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970029-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Evaluation of an immunoblot assay for serological confirmation and differentiation of human T-cell lymphotropic virus types I and II.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970029-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(95)70029-3

1 reference

15 December 2017

1 reference

15 December 2017